Vaginal cancer staging: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) No edit summary |
(→FIGO) |
||
| (11 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | {{CMG}} {{AE}} {{sali}} | ||
{{Vaginal cancer}} | {{Vaginal cancer}} | ||
==Overview== | ==Overview== | ||
Vaginal cancer may be classified into 4 subtypes based on FIGO or AJCC staging system. | [[Vaginal cancer]] may be classified into 4 subtypes based on [[FIGO]] or [[AJCC]] staging system. | ||
==Staging== | ==Staging== | ||
The Féderation Internationale de Gynécologie et d’Obstétrique (FIGO) and the American Joint Committee on Cancer (AJCC) have designated staging to define vaginal cancer; the FIGO system is most commonly used. The definitions of the AJCC's T, N, and M categories correspond to the stages accepted by FIGO.<ref name="cancergov"> National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq </ref> | The Féderation Internationale de Gynécologie et d’Obstétrique ([[FIGO]]) and the American Joint Committee on Cancer ([[AJCC]]) have designated staging to define [[vaginal cancer]]; the [[FIGO]] system is most commonly used<ref name="pmid26411952">{{cite journal |vauthors=Shrivastava SB, Agrawal G, Mittal M, Mishra P |title=Management of Vaginal Cancer |journal=Rev Recent Clin Trials |volume=10 |issue=4 |pages=289–97 |date=2015 |pmid=26411952 |doi= |url=}}</ref>. The definitions of the AJCC's T, N, and M categories correspond to the stages accepted by FIGO.<ref name="cancergov"> National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq </ref> | ||
===FIGO=== | ===FIGO=== | ||
FIGO staging system (and modified World Health Organization [WHO] prognostic scoring system) | [[FIGO]] staging system (and modified [[World Health Organization]] ([[WHO]]) prognostic scoring system)<ref name="pmid25847318">{{cite journal |vauthors=Rajaram S, Maheshwari A, Srivastava A |title=Staging for vaginal cancer |journal=Best Pract Res Clin Obstet Gynaecol |volume=29 |issue=6 |pages=822–32 |date=August 2015 |pmid=25847318 |doi=10.1016/j.bpobgyn.2015.01.006 |url=}}</ref> | ||
The FIGO staging system is as follows: | The [[FIGO]] staging system is as follows<ref name="pmid30306589">{{cite journal |vauthors=Adams TS, Cuello MA |title=Cancer of the vagina |journal=Int J Gynaecol Obstet |volume=143 Suppl 2 |issue= |pages=14–21 |date=October 2018 |pmid=30306589 |doi=10.1002/ijgo.12610 |url=}}</ref>: | ||
[[File:Vaginal cancer1.png|thumb|none|400px|This image is provided by the National Library of Medicine.]] | [[File:Vaginal cancer1.png|thumb|none|400px|This image is provided by the National Library of Medicine.]] | ||
| Line 24: | Line 24: | ||
===Stage I=== | ===Stage I=== | ||
* T1, N0, M0 | * T1, N0, M0<ref name="pmid27327154">{{cite journal |vauthors=Jain V, Sekhon R, Giri S, Bora RR, Batra K, Bajracharya A, Rawal S |title=Role of Radical Surgery in Early Stages of Vaginal Cancer-Our Experience |journal=Int. J. Gynecol. Cancer |volume=26 |issue=6 |pages=1176–81 |date=July 2016 |pmid=27327154 |doi=10.1097/IGC.0000000000000743 |url=}}</ref> | ||
===Stage II=== | ===Stage II=== | ||
| Line 32: | Line 32: | ||
===Stage III=== | ===Stage III=== | ||
* T1, N1, M0 | * T1, N1, M0<ref name="pmid29086206">{{cite journal |vauthors=Ikushima H, Wakatsuki M, Ariga T, Kaneyasu Y, Tokumaru S, Isohashi F, Ii N, Uno T, Ohno T, Arisawa K, Toita T |title=Radiotherapy for vaginal cancer: a multi-institutional survey study of the Japanese Radiation Oncology Study Group |journal=Int. J. Clin. Oncol. |volume=23 |issue=2 |pages=314–320 |date=April 2018 |pmid=29086206 |doi=10.1007/s10147-017-1205-z |url=}}</ref> | ||
* T2, N1, M0 | * T2, N1, M0 | ||
* T3, N0, M0 | * T3, N0, M0 | ||
| Line 47: | Line 47: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Gynecology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gynecology]] | |||
Latest revision as of 13:21, 6 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]
|
Vaginal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vaginal cancer staging On the Web |
|
American Roentgen Ray Society Images of Vaginal cancer staging |
|
Risk calculators and risk factors for Vaginal cancer staging |
Overview
Vaginal cancer may be classified into 4 subtypes based on FIGO or AJCC staging system.
Staging
The Féderation Internationale de Gynécologie et d’Obstétrique (FIGO) and the American Joint Committee on Cancer (AJCC) have designated staging to define vaginal cancer; the FIGO system is most commonly used[1]. The definitions of the AJCC's T, N, and M categories correspond to the stages accepted by FIGO.[2]
FIGO
FIGO staging system (and modified World Health Organization (WHO) prognostic scoring system)[3]
The FIGO staging system is as follows[4]:
AJCC Stage Groupings
Stage 0
- Tis, N0, M0
Stage I
- T1, N0, M0[5]
Stage II
- T2, N0, M0
Stage III
- T1, N1, M0[6]
- T2, N1, M0
- T3, N0, M0
- T3, N1, M0
Stage IVA
- T4, any N, M0
Stage IVB
- Any T, any N, M1
References
- ↑ Shrivastava SB, Agrawal G, Mittal M, Mishra P (2015). "Management of Vaginal Cancer". Rev Recent Clin Trials. 10 (4): 289–97. PMID 26411952.
- ↑ National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq
- ↑ Rajaram S, Maheshwari A, Srivastava A (August 2015). "Staging for vaginal cancer". Best Pract Res Clin Obstet Gynaecol. 29 (6): 822–32. doi:10.1016/j.bpobgyn.2015.01.006. PMID 25847318.
- ↑ Adams TS, Cuello MA (October 2018). "Cancer of the vagina". Int J Gynaecol Obstet. 143 Suppl 2: 14–21. doi:10.1002/ijgo.12610. PMID 30306589.
- ↑ Jain V, Sekhon R, Giri S, Bora RR, Batra K, Bajracharya A, Rawal S (July 2016). "Role of Radical Surgery in Early Stages of Vaginal Cancer-Our Experience". Int. J. Gynecol. Cancer. 26 (6): 1176–81. doi:10.1097/IGC.0000000000000743. PMID 27327154.
- ↑ Ikushima H, Wakatsuki M, Ariga T, Kaneyasu Y, Tokumaru S, Isohashi F, Ii N, Uno T, Ohno T, Arisawa K, Toita T (April 2018). "Radiotherapy for vaginal cancer: a multi-institutional survey study of the Japanese Radiation Oncology Study Group". Int. J. Clin. Oncol. 23 (2): 314–320. doi:10.1007/s10147-017-1205-z. PMID 29086206.